No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
BOLT Bolt Biotherapeutics
- 0.539
- -0.031-5.42%
Trading Dec 31 15:52 ET
20.63MMarket Cap-0.32P/E (TTM)
0.585High0.535Low189.32KVolume0.585Open0.570Pre Close103.57KTurnover0.69%Turnover RatioLossP/E (Static)38.27MShares1.56052wk High0.29P/B14.78MFloat Cap0.47552wk Low--Dividend TTM27.41MShs Float43.070Historical High--Div YieldTTM8.77%Amplitude0.475Historical Low0.547Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Bolt Biotherapeutics Announces Board Changes and Appointments
Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Bolt Biotherapeutics (BOLT) and Amarin (AMRN)
Bolt Biotherapeutics' Restructuring Faces Potential Setbacks: A Closer Look
Bolt Biotherapeutics GAAP EPS of -$0.40, Revenue of $1.14M
Stifel Maintains Bolt Biotherapeutics(BOLT.US) With Hold Rating, Maintains Target Price $1.5
H.C. Wainwright Maintains Bolt Biotherapeutics(BOLT.US) With Hold Rating
Heat List
US
Overall
Symbol
Price
% Chg
No Data
